VCM
BVS icon

Versant Capital Management’s Bioventus BVS Stock Holding History

Versant Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77K Hold
293
– – ﹤0.01% 2522
2026
Q1 		$2.67K Buy
+293
New +$2.46K ﹤0.01% 2515

Other funds holding BVS

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
QFP
Quantum Financial Partners Overland Park, Kansas $196M AUM
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Versant Capital Management's BVS Position: Q2 2026 in Review

Versant Capital Management held its Bioventus (BVS) position steady in Q2 2026 at 293 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #2522.

Versant Capital Management first reported a position in BVS in Q1 2026 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Versant Capital Management held 293 shares of Bioventus worth $2.77K as of Q2 2026.
  • Versant Capital Management left its Bioventus share count unchanged in Q2 2026.
  • Bioventus made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2522 holding.
  • Versant Capital Management first reported a position in Bioventus in Q1 2026 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.